IRIDEX (IRIX)
(Real Time Quote from BATS)
$2.07 USD
-0.05 (-2.36%)
Updated Jul 16, 2024 03:28 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IRIX 2.07 -0.05(-2.36%)
Will IRIX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for IRIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRIX
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
Lumentum (LITE) Q3 Earnings Beat Estimates
IRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Industry Outlook Highlights MicroVision, Cutera and IRIDEX
3 Laser Systems Stocks to Watch in a Challenging Industry
Other News for IRIX
Iridex Leadership and Governance Strengthened at Annual Meeting
IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
Iridex on the Brink: Operational Losses and Funding Woes Threaten Company Viability
Analysts Offer Insights on Healthcare Companies: Iridex (IRIX), Nyxoah (NYXH) and Enliven Therapeutics (ELVN)
IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...